Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • May 18 2012

    Advaxis, Inc. announced the closing of their Registered Direct offering in the amount of $715,000. EG&S acted as counsel to the placement agent.

  • May 15 2012

    Douglas S. Ellenoff, a member of the Firm, participated in Washington DC's first national crowdfunding conference.  CrowdCheck hosted experts from the US Small Business Administration, Capitol Hill, think tanks, startups and the securities industry at the conference, entitled "The Wisdom of the Crowd." Mr. Ellenoff spoke on fraud prevention for crowdfunding.

  • May 11 2012

    Douglas S. Ellenoff, a member of the Firm, spoke at New York's first Crowdfunding 101 Workshop. He spoke about the firm's role in the process that generated the JOBS Act, our current activity in assisting with the SEC's rule-making process and the current & future legal issues that will effect crowdfunding platforms planning to present equity-based crowdfunding solutions for small businesses.

  • May 01 2012

    University General Health Systems, Inc. announced the closing of their Registered Direct offering in the amount of $3,100,000.  EG&S acted as counsel to the Investor.

  • April 25 2012

    Oculus Innovative Sciences, Inc. announced the closing of their Registered Direct offering in the amount of $3,124,000.  EG&S acted as counsel to the placement agent.
     

  • April 20 2012

    Douglas S. Ellenoff, a member of the Firm, attended meetings between several department heads of the SEC and the crowdfunding industry, including the The National Crowdfunding Association (NLCFA).

    Click here to read Mr. Ellenoff's notes from the meetings

  • April 19 2012

    Ellenoff Grossman & Schole LLP was the premier sponsor at Deal Flow Media's CrowdFunding Conference, in New York City.  Douglas S. Ellenoff, a member of the Firm, opened the conference with his keynote address focusing on the outlook of the CrowdFunding Market.  Sarah E. Williams, also a member of the Firm, moderated the panel: Understanding Policy Issues vs. Securities Rules if you're in the CrowdFunding Business.
     

  • April 18 2012

    Titan Pharmaceuticals,Inc. announced the closing of their Registered Direct offering in the amount of $5,540,000.  EG&S acted as counsel to the placement agent.
     

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”